The CHEERS-AI Steering Group (2024) Consolidated health economic evaluation reporting standards for interventions that use Artificial Intelligence (CHEERS-AI). Value in Health, 27 (9). 1196 - 1205. ISSN 1098-3015
Text (Srivastava_consolidated-health-economic-evaluation--published)
- Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (495kB) |
Abstract
Objectives: Economic evaluations (EEs) are commonly used by decision makers to understand the value of health interventions. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS 2022) provide reporting guidelines for EEs. Healthcare systems will increasingly see new interventions that use artificial intelligence (AI) to perform their function. We developed Consolidated Health Economic Evaluation Reporting Standards for Interventions that use AI (CHEERS-AI) to ensure EEs of AI-based health interventions are reported in a transparent and reproducible manner. Methods: Potential CHEERS-AI reporting items were informed by 2 published systematic literature reviews of EEs and a contemporary update. A Delphi study was conducted using 3 survey rounds to elicit multidisciplinary expert views on 26 potential items, through a 9-point Likert rating scale and qualitative comments. An online consensus meeting was held to finalize outstanding reporting items. A digital health patient group reviewed the final checklist from a patient perspective. Results: A total of 58 participants responded to survey round 1, 42, and 31 of whom responded to rounds 2 and 3, respectively. Nine participants joined the consensus meeting. Ultimately, 38 reporting items were included in CHEERS-AI. They comprised the 28 original CHEERS 2022 items, plus 10 new AI-specific reporting items. Additionally, 8 of the original CHEERS 2022 items were elaborated on to ensure AI-specific nuance is reported. Conclusions: CHEERS-AI should be used when reporting an EE of an intervention that uses AI to perform its function. CHEERS-AI will help decision makers and reviewers to understand important AI-specific details of an intervention, and any implications for the EE methods used and cost-effectiveness conclusions.
Item Type: | Article |
---|---|
Official URL: | https://www.valueinhealthjournal.com/ |
Additional Information: | © 2024 International Society for Pharmacoeconomics and Outcomes Research, Inc. |
Divisions: | Social Policy Health Policy LSE Health |
Subjects: | R Medicine > RA Public aspects of medicine |
Date Deposited: | 01 Jul 2024 16:12 |
Last Modified: | 20 Dec 2024 00:55 |
URI: | http://eprints.lse.ac.uk/id/eprint/124070 |
Actions (login required)
View Item |